Noile-Immune Biotech Inc. (4893.T)

JPY 163.0

(-1.81%)

Market Cap (In JPY)

7.05 Billion

Revenue (In JPY)

316.81 Million

Net Income (In JPY)

-1.13 Billion

Avg. Volume

3.64 Million

Currency
JPY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
121.0-353.0
PE
-
EPS
-
Beta Value
0.0
ISIN
JP3759560000
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Koji Tamada M.D., Ph.D.
Employee Count
-
Website
https://www.noile-immune.com
Ipo Date
2023-06-28
Details
Noile-Immune Biotech Inc. researches and develops CAR-T cells for cancer immunotherapies. The company was incorporated in 2015 and is headquartered in Minato, Japan.